Copyright Reports & Markets. All rights reserved.

Global Healthcare Artificial Intelligence Market Report 2018-2029

Request for Sample of this report
Buy now

1 Industry Overview of Healthcare Artificial Intelligence

  • 1.1 Research Scope
  • 1.2 Market Segmentation by Types of Healthcare Artificial Intelligence
  • 1.3 Market Segmentation by End Users of Healthcare Artificial Intelligence
  • 1.4 Market Dynamics Analysis of Healthcare Artificial Intelligence
    • 1.4.1 Market Drivers
    • 1.4.2 Market Challenges
    • 1.4.3 Market Opportunities
    • 1.4.4 Porter’s Five Forces

2 Major Manufacturers Analysis of Healthcare Artificial Intelligence Industry

  • 2.1 AiCure
    • 2.1.1 Company Overview
    • 2.1.2 Main Products and Specifications
    • 2.1.3 Healthcare Artificial Intelligence Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.1.4 Contact Information
  • 2.2 Cyrcadia Health
    • 2.2.1 Company Overview
    • 2.2.2 Main Products and Specifications
    • 2.2.3 Healthcare Artificial Intelligence Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.2.4 Contact Information
  • 2.3 Google
    • 2.3.1 Company Overview
    • 2.3.2 Main Products and Specifications
    • 2.3.3 Healthcare Artificial Intelligence Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.3.4 Contact Information
  • 2.4 IBM
    • 2.4.1 Company Overview
    • 2.4.2 Main Products and Specifications
    • 2.4.3 Healthcare Artificial Intelligence Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.4.4 Contact Information
  • 2.5 Microsoft
    • 2.5.1 Company Overview
    • 2.5.2 Main Products and Specifications
    • 2.5.3 Healthcare Artificial Intelligence Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.5.4 Contact Information
  • 2.6 Atomwise
    • 2.6.1 Company Overview
    • 2.6.2 Main Products and Specifications
    • 2.6.3 Healthcare Artificial Intelligence Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.6.4 Contact Information
  • 2.7 Lifegraph
    • 2.7.1 Company Overview
    • 2.7.2 Main Products and Specifications
    • 2.7.3 Healthcare Artificial Intelligence Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.7.4 Contact Information
  • 2.8 Modernizing Medicine
    • 2.8.1 Company Overview
    • 2.8.2 Main Products and Specifications
    • 2.8.3 Healthcare Artificial Intelligence Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.8.4 Contact Information
  • 2.9 Sensely
    • 2.9.1 Company Overview
    • 2.9.2 Main Products and Specifications
    • 2.9.3 Healthcare Artificial Intelligence Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.9.4 Contact Information
  • 2.10 Zebra Medical Vision
    • 2.10.1 Company Overview
    • 2.10.2 Main Products and Specifications
    • 2.10.3 Healthcare Artificial Intelligence Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.10.4 Contact Information
  • 2.11 Sophia Genetics
    • 2.11.1 Company Overview
    • 2.11.2 Main Products and Specifications
    • 2.11.3 Healthcare Artificial Intelligence Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.11.4 Contact Information
  • 2.12 Welltok
    • 2.12.1 Company Overview
    • 2.12.2 Main Products and Specifications
    • 2.12.3 Healthcare Artificial Intelligence Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.12.4 Contact Information
  • 2.13 APIXIO
    • 2.13.1 Company Overview
    • 2.13.2 Main Products and Specifications
    • 2.13.3 Healthcare Artificial Intelligence Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.13.4 Contact Information
  • 2.14 Insilico Medicine
    • 2.14.1 Company Overview
    • 2.14.2 Main Products and Specifications
    • 2.14.3 Healthcare Artificial Intelligence Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.14.4 Contact Information
  • 2.15 Pathway Genomics
    • 2.15.1 Company Overview
    • 2.15.2 Main Products and Specifications
    • 2.15.3 Healthcare Artificial Intelligence Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.15.4 Contact Information
  • 2.16 Enlitic
    • 2.16.1 Company Overview
    • 2.16.2 Main Products and Specifications
    • 2.16.3 Healthcare Artificial Intelligence Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.16.4 Contact Information

3 Global Healthcare Artificial Intelligence Market Analysis by Regions, Manufacturers, Types and End Users

  • 3.1 Global Sales Volume and Revenue of Healthcare Artificial Intelligence by Regions (2018-2023)
  • 3.2 Global Sales Volume and Revenue of Healthcare Artificial Intelligence by Manufacturers (2018-2023)
  • 3.3 Global Sales Volume and Revenue of Healthcare Artificial Intelligence by Types (2018-2023)
  • 3.4 Global Sales Volume and Revenue of Healthcare Artificial Intelligence by End Users (2018-2023)
  • 3.5 Selling Price Analysis of Healthcare Artificial Intelligence by Regions, Manufacturers, Types and End Users in (2018-2023)

4 Northern America Healthcare Artificial Intelligence Market Analysis by Countries, Types and End Users

  • 4.1 Northern America Healthcare Artificial Intelligence Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 4.2 Northern America Healthcare Artificial Intelligence Sales Volume and Revenue Analysis by Types (2018-2023)
  • 4.3 Northern America Healthcare Artificial Intelligence Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 4.4 United States Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 4.5 Canada Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)

5 Europe Healthcare Artificial Intelligence Market Analysis by Countries, Types and End Users

  • 5.1 Europe Healthcare Artificial Intelligence Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 5.2 Europe Healthcare Artificial Intelligence Sales Volume and Revenue Analysis by Types (2018-2023)
  • 5.3 Europe Healthcare Artificial Intelligence Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 5.4 Germany Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.5 France Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.6 UK Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.7 Italy Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.8 Russia Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.9 Spain Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.10 Netherlands Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)

6 Asia Pacific Healthcare Artificial Intelligence Market Analysis by Countries, Types and End Users

  • 6.1 Asia Pacific Healthcare Artificial Intelligence Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 6.2 Asia Pacific Healthcare Artificial Intelligence Sales Volume and Revenue Analysis by Types (2018-2023)
  • 6.3 Asia Pacific Healthcare Artificial Intelligence Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 6.4 China Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.5 Japan Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.6 Korea Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.7 India Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.8 Australia Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.9 Indonesia Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.10 Vietnam Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)

7 Latin America Healthcare Artificial Intelligence Market Analysis by Countries, Types and End Users

  • 7.1 Latin America Healthcare Artificial Intelligence Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 7.2 Latin America Healthcare Artificial Intelligence Sales Volume and Revenue Analysis by Types (2018-2023)
  • 7.3 Latin America Healthcare Artificial Intelligence Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 7.4 Brazil Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 7.5 Mexico Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 7.6 Argentina Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 7.7 Colombia Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)

8 Middle East & Africa Healthcare Artificial Intelligence Market Analysis by Countries, Types and End Users

  • 8.1 Middle East & Africa Healthcare Artificial Intelligence Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 8.2 Middle East & Africa Healthcare Artificial Intelligence Sales Volume and Revenue Analysis by Types (2018-2023)
  • 8.3 Middle East & Africa Healthcare Artificial Intelligence Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 8.4 Turkey Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 8.5 Saudi Arabia Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 8.6 South Africa Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 8.7 Egypt Healthcare Artificial Intelligence Sales Volume, Revenue, Import and Export Analysis (2018-2023)

9 Marketing Channel, Distributors and Traders Analysis

  • 9.1 Marketing Channel
    • 9.1.1 Direct Channel
    • 9.1.2 Indirect Channel
  • 9.2 Distributors and Traders

10 Global Healthcare Artificial Intelligence Market Forecast by Regions, Countries, Manufacturers, Types and End Users

  • 10.1 Global Sales Volume and Revenue Forecast of Healthcare Artificial Intelligence by Regions (2024-2029)
  • 10.2 Global Sales Volume and Revenue Forecast of Healthcare Artificial Intelligence by Types (2024-2029)
  • 10.3 Global Sales Volume and Revenue Forecast of Healthcare Artificial Intelligence by End Users (2024-2029)
  • 10.4 Global Revenue Forecast of Healthcare Artificial Intelligence by Countries (2024-2029)
    • 10.4.1 United States Revenue Forecast (2024-2029)
    • 10.4.2 Canada Revenue Forecast (2024-2029)
    • 10.4.3 Germany Revenue Forecast (2024-2029)
    • 10.4.4 France Revenue Forecast (2024-2029)
    • 10.4.5 UK Revenue Forecast (2024-2029)
    • 10.4.6 Italy Revenue Forecast (2024-2029)
    • 10.4.7 Russia Revenue Forecast (2024-2029)
    • 10.4.8 Spain Revenue Forecast (2024-2029)
    • 10.4.9 Netherlands Revenue Forecast (2024-2029)
    • 10.4.10 China Revenue Forecast (2024-2029)
    • 10.4.11 Japan Revenue Forecast (2024-2029)
    • 10.4.12 Korea Revenue Forecast (2024-2029)
    • 10.4.13 India Revenue Forecast (2024-2029)
    • 10.4.14 Australia Revenue Forecast (2024-2029)
    • 10.4.15 Indonesia Revenue Forecast (2024-2029)
    • 10.4.16 Vietnam Revenue Forecast (2024-2029)
    • 10.4.17 Brazil Revenue Forecast (2024-2029)
    • 10.4.18 Mexico Revenue Forecast (2024-2029)
    • 10.4.19 Argentina Revenue Forecast (2024-2029)
    • 10.4.20 Colombia Revenue Forecast (2024-2029)
    • 10.4.21 Turkey Revenue Forecast (2024-2029)
    • 10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
    • 10.4.23 South Africa Revenue Forecast (2024-2029)
    • 10.4.24 Egypt Revenue Forecast (2024-2029)

11 Industry Chain Analysis of Healthcare Artificial Intelligence

  • 11.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Healthcare Artificial Intelligence
    • 11.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Healthcare Artificial Intelligence
    • 11.1.2 Major Equipment Suppliers with Contact Information Analysis of Healthcare Artificial Intelligence
  • 11.2 Downstream Major Consumers Analysis of Healthcare Artificial Intelligence
  • 11.3 Major Suppliers of Healthcare Artificial Intelligence with Contact Information
  • 11.4 Supply Chain Relationship Analysis of Healthcare Artificial Intelligence

12 Healthcare Artificial Intelligence New Project Investment Feasibility Analysis

  • 12.1 Healthcare Artificial Intelligence New Project SWOT Analysis
  • 12.2 Healthcare Artificial Intelligence New Project Investment Feasibility Analysis
    • 12.2.1 Project Name
    • 12.2.2 Investment Budget
    • 12.2.3 Project Product Solutions
    • 12.2.4 Project Schedule

13 Healthcare Artificial Intelligence Research Findings and Conclusion

    14 Appendix

    • 14.1 Research Methodology
    • 14.2 References and Data Sources
      • 14.2.1 Primary Sources
      • 14.2.2 Secondary Paid Sources
      • 14.2.3 Secondary Public Sources
    • 14.3 Abbreviations and Units of Measurement
    • 14.4 Author Details

    The Healthcare Artificial Intelligence (AI) industry is revolutionizing the healthcare sector by harnessing the power of advanced technologies to improve patient care, enhance diagnostic accuracy, streamline operations, and facilitate drug discovery. In this article, we will delve into the definition of Healthcare Artificial Intelligence, its diverse applications in drug discovery, medical imaging, and diagnosis, the current status of the industry, and the promising prospects it holds.

    Healthcare Artificial Intelligence can be defined as the application of AI techniques, including machine learning, natural language processing, and computer vision, in healthcare settings to analyze complex medical data, make predictions, assist in decision-making, and develop innovative solutions to healthcare challenges. By leveraging large datasets, algorithms, and computational power, Healthcare AI enables healthcare professionals to gain valuable insights, improve clinical outcomes, and deliver more personalized and efficient care.

    The use of Healthcare Artificial Intelligence spans various domains within the healthcare industry. In drug discovery, AI algorithms can analyze vast amounts of biological and chemical data to identify potential drug candidates, predict their efficacy, and accelerate the development process. Medical imaging is another crucial area where AI has made significant strides. By analyzing medical images such as X-rays, CT scans, and MRIs, AI algorithms can aid in the detection of abnormalities, assist radiologists in making accurate diagnoses, and improve patient outcomes. Additionally, AI-powered diagnostic systems can analyze patient data, symptoms, and medical histories to provide accurate and timely diagnoses, reducing errors and improving treatment plans.

    According to market research, the global Healthcare Artificial Intelligence market size is projected to reach approximately US$8,881 million in 2022, with a compound annual growth rate (CAGR) of 45.8%. This exponential growth is driven by several factors, including the increasing availability and accessibility of healthcare data, advancements in AI technologies, the need for improved patient outcomes, and the rising demand for personalized medicine.

    Major global manufacturers in the Healthcare AI industry include AiCure, Cyrcadia Health, Google, IBM, Microsoft, Atomwise, Lifegraph, Modernizing Medicine, Sensely, Zebra Medical Vision, Sophia Genetics, Welltok, APIXIO, Insilico Medicine, Pathway Genomics, and Enlitic. These manufacturers are at the forefront of developing innovative AI-powered solutions, collaborating with healthcare providers, and leveraging their expertise in data analytics, machine learning, and medical research.

    The current state of the Healthcare Artificial Intelligence industry is characterized by rapid advancements and increasing adoption across healthcare organizations worldwide. AI algorithms and systems are continually improving in accuracy, speed, and performance, providing clinicians with valuable insights and augmenting their decision-making capabilities. The industry has witnessed significant developments in deep learning algorithms, natural language processing models, and computer vision techniques, enabling more accurate diagnoses, personalized treatment plans, and efficient healthcare delivery.

    Looking ahead, the prospects for the Healthcare Artificial Intelligence industry are highly promising. With a projected market size of approximately US$8,881 million in 2022 and a compound annual growth rate (CAGR) of 45.8%, the industry is expected to witness robust expansion and transformative innovations. Factors such as the growing availability of healthcare data, increased investments in AI research and development, and the need for efficient and cost-effective healthcare solutions will continue to propel the market's growth.

    However, challenges exist that need to be addressed to fully unlock the potential of Healthcare Artificial Intelligence. These include regulatory considerations, ethical concerns regarding patient privacy and data security, integration challenges with existing healthcare systems and workflows, and the need for interdisciplinary collaboration between AI experts, healthcare professionals, and policymakers.

    Collaboration between manufacturers, healthcare providers, researchers, and regulatory bodies will be vital in driving the growth and success of the Healthcare AI industry. Continued investment in AI research and development, ensuring transparency and accountability in algorithm development, and addressing the ethical and regulatory complexities will further promote the adoption and acceptance of Healthcare Artificial Intelligence in the healthcare ecosystem.

    In conclusion, the Healthcare Artificial Intelligence industry is revolutionizing healthcare by leveraging advanced technologies to improve patient care, enhance diagnostic accuracy, and streamline operations. With a projected market size of approximately US$8,881 million in 2022 and a compound annual growth rate (CAGR) of 45.8%, the industry is poised for remarkable growth and transformative innovations. Major global manufacturers are leading the way through their expertise in AI technologies and collaborations with healthcare organizations. By addressing challenges and leveraging opportunities, the Healthcare Artificial Intelligence industry can contribute to advancements in healthcare delivery, patient outcomes, and personalized medicine.

    The SWOT analysis of the Healthcare Artificial Intelligence industry is as follows:

    Strengths:
    Enhanced Diagnostic Accuracy: AI algorithms can analyze vast amounts of medical data with high accuracy, leading to improved diagnostic capabilities and more precise treatment plans.
    Efficiency and Cost-Effectiveness: AI-powered systems can streamline healthcare operations, reduce manual tasks, and optimize resource utilization, resulting in cost savings and increased efficiency.
    Personalized Medicine: Healthcare AI enables personalized treatment plans by analyzing patient data, genetics, and medical history, leading to targeted therapies and better patient outcomes.
    Drug Discovery Acceleration: AI algorithms can analyze large datasets, identify potential drug candidates, and predict their efficacy, accelerating the drug discovery process and reducing costs.
    Improved Patient Care: AI systems can assist healthcare professionals in making informed decisions, reducing errors, and improving overall patient care.

    Weaknesses:
    Dependency on Data Quality: Healthcare AI heavily relies on high-quality and diverse datasets for accurate predictions. Inadequate or biased data can lead to inaccurate results and potential biases in decision-making.
    Regulatory Challenges: The healthcare industry is subject to stringent regulations. Compliance with privacy, security, and ethical guidelines poses challenges for AI systems handling patient data.
    Limited Human Interaction: The integration of AI in healthcare may reduce human interaction, potentially affecting the doctor-patient relationship and the emotional aspect of care.
    Initial Investment and Training: Implementing AI technologies requires substantial initial investment, including hardware, software, and training. This can be a barrier to adoption for smaller healthcare organizations.

    Opportunities:
    Advanced Imaging and Diagnostics: AI can significantly enhance medical imaging interpretation, aiding radiologists in detecting abnormalities and improving diagnostic accuracy.
    Remote Patient Monitoring: AI-powered wearables and monitoring systems can facilitate remote patient monitoring, enabling early detection of health issues and reducing hospitalization rates.
    Predictive Analytics: AI algorithms can analyze patient data to predict disease progression, identify populations at risk, and facilitate preventive interventions.
    Telemedicine and Virtual Assistants: AI can enhance telemedicine consultations by providing intelligent virtual assistants that gather patient information, assist in diagnosis, and offer personalized recommendations.
    Collaboration and Partnerships: The healthcare AI industry presents opportunities for collaboration between technology companies, healthcare providers, and research institutions to develop innovative solutions and drive advancements in the field.

    Threats:
    Data Security and Privacy Concerns: Handling sensitive patient data raises concerns about privacy breaches and cybersecurity threats, potentially undermining trust in AI-powered healthcare systems.
    Ethical Considerations: AI algorithms may introduce biases or make decisions that conflict with ethical standards, raising concerns about transparency, fairness, and accountability.
    Resistance to Adoption: Some healthcare professionals may resist AI adoption due to fear of job displacement or skepticism about AI's reliability and effectiveness.
    Technological Limitations: AI algorithms are not infallible and may have limitations in specific medical scenarios or when facing novel diseases or complex cases.
    Legal and Regulatory Challenges: Healthcare AI must comply with various legal and regulatory frameworks, including data protection, liability, and safety regulations, which may pose challenges for implementation and scalability.

    Key players in global Healthcare Artificial Intelligence market include:
    AiCure
    Cyrcadia Health
    Google
    IBM
    Microsoft
    Atomwise
    Lifegraph
    Modernizing Medicine
    Sensely
    Zebra Medical Vision
    Sophia Genetics
    Welltok
    APIXIO
    Insilico Medicine
    Pathway Genomics
    Enlitic

    Market segmentation, by product types:
    Type 1
    Type 2
    Type 3

    Market segmentation, by applications:
    Drug Discovery
    Medical Imaging
    Diagnosis
    Buy now